3 February 2025
Imfinzi recommended for approval in the EU by CHMP as first and only immunotherapy for limited-stage small cell lung cancer Recommendation based on ADRIATIC Phase…
3i Infrastructure plc – Performance update Portfolio performing well, with attractive growth opportunities. Recent realisations demonstrate value creation potential. 3i Infrastructure plc (‘3iN’ or…
HgCapital Trust plc PRELIMINARY TRADING UPDATE FOR THE YEAR ENDED 31 DECEMBER 2024 ESTIMATED NAV PERFORMANCE DRIVEN BY RESILIENT TRADING IN THE UNDERLYING PORTFOLIO…
31 January 2025 JAMES HALSTEAD PLC(the “Company”) Trading Update and Notice of Results James Halstead plc, the commercial flooring manufacturer and international distributor, is…
30 January 2025
SUMMARY OF UNAUDITED RESULTS Quarters $ million Full year $ million Q4 2024 Q3 2024 Q4 2023 %1 2024 2023 % 928…
TREATT PLC (“Treatt” or “the Group”) AGM Trading Update Treatt, the manufacturer and supplier of a diverse and sustainable portfolio of natural extracts and…
Fevertree Drinks plc (“Fever-Tree” or the “Company”) Fever-Tree announces a Strategic Partnership with Molson Coors to drive the next stage of growth in the…
29 January 2025
HARGREAVES SERVICES PLC (the “Group”, the “Company” or “Hargreaves”) Interim Results for the six months ended 30 November 2024 Hargreaves Services plc (AIM: HSP),…